Empowered Funds
NMRA icon

Empowered Funds’s Neumora Therapeutics NMRA Stock Holding History

Empowered Funds’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$132K Buy
+221,217
New +$306K ﹤0.01% 2374

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Affinity Asset Advisors
Affinity Asset Advisors New York $2.46B AUM 196.28% 1-Year Est. Return
MIC Capital Management (UK)
MIC Capital Management (UK) London, United Kingdom $463M AUM 7.9% 1-Year Est. Return
Exor N.V.
Exor N.V. Amsterdam, Netherlands $26.6B AUM 9.51% 1-Year Est. Return
Wellcome Trust
Wellcome Trust London, United Kingdom $9.16B AUM 11.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Lunate Capital
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $714M AUM 64.22% 1-Year Est. Return

Empowered Funds's NMRA Position: Q3 2026 in Review

Empowered Funds opened a new position in Neumora Therapeutics (NMRA) in Q3 2026: 221,217 shares worth $132K. The stake represents ﹤0.01% of the portfolio and ranks #2374 among its holdings.

85 funds tracked by Wall St. Rank hold NMRA as of Q3 2026.

  • Empowered Funds held 221,217 shares of Neumora Therapeutics worth $132K as of Q3 2026.
  • Neumora Therapeutics was a new Empowered Funds position in Q3 2026.
  • Neumora Therapeutics made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2374 holding.
  • 85 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.